Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Overweight 1Obesity 1Non-alcoholic Fatty Liver Disease 1

Interventions

Metformin 9Liraglutide 3Exercise 3semaglutide 2Tirzepatide 2Nutrition Assessment 2Docosahexaenoic Acids 2Diet 2sibutramine 1Ursodeoxycholic Acid 1Topiramate 1Solutions 1Resistance Training 1Propofol 1Progestins 1Nutrition Therapy 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Injections 1Hysteroscopy 1Exenatide 1Estrogen Replacement Therapy 1Doxorubicin 1Cyproterone 1Cyclophosphamide 1Caloric Restriction 1(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Obesity × Ursodeoxycholic Acid × Clear all
NCT06918080 2025-04-09

Hepatoprotective Measures for Children at High Risk of NAFLD

Ain Shams University

Phase 4 Active not recruiting
200 enrolled
LymphoidOtherOther hematologic neoplasm

Obesity, Overweight, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡